Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 27, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019643

« Back to Dashboard
NDA 019643 describes MEVACOR, which is a drug marketed by Merck and is included in one NDA. Additional details are available on the MEVACOR profile page.

The generic ingredient in MEVACOR is lovastatin. There are thirty-three drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the lovastatin profile page.

Summary for NDA: 019643

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Mar 28, 1991TE:RLD:Yes

Summary for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength20MG **Federal Register notice that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Aug 31, 1987TE:RLD:Yes

Summary for product number 004

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength40MG **Federal Register notice that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Dec 14, 1988TE:RLD:Yes

Expired Orange Book Patents for NDA: 019643

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck
MEVACOR
lovastatin
TABLET;ORAL019643-004Dec 14, 19884,231,938*PED► Subscribe
Merck
MEVACOR
lovastatin
TABLET;ORAL019643-002Mar 28, 19914,231,938*PED► Subscribe
Merck
MEVACOR
lovastatin
TABLET;ORAL019643-003Aug 31, 19874,231,938*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot